Status:
TERMINATED
Treatment Chronic UTI Post Kidney Transplant
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Urinary Tract Infections
Transplant-Related Disorder
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
Urinary tract infections (UTIs) with extended-spectrum -lactamase (ESBL)-positive Enterobacteriums (ESBL-E) are a common infectious complication of renal transplant recipients, with 10% of patients su...
Detailed Description
According to each patient's urine culture, resistant urinary tract infections will be treated with specific phages and patients will be followed up with their urine cultures for response to therapy.
Eligibility Criteria
Inclusion
- Stable Kidney Transplant Recipients
- Stable Immunosupression Dose
- Stable Renal Function
- Resistant Urinary Infection with Positive UC
Exclusion
- Rejection periods
- Frail Patients
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05967130
Start Date
July 1 2023
End Date
July 1 2024
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nooshin Dalili
Tehran, Iran, 1666663421